Antiviral therapy for hepatitis B and C in Asians

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue SUPPL., 1999, Pages

  Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antiviral therapy; Asians; Hepatitis B; Hepatitis C

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; LAMIVUDINE;

ARTICLE; ASIAN; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; PRIORITY JOURNAL; VIRUS LOAD; VIRUS STRAIN;

EID: 0033014669     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01879.x     Document Type: Article

References (7)

1. Prescott LE, Simmonds P, Lai CL et al. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong. J. Med. Virol. 1996; 50: 168-75.
2. Lok ASF, Lai CL, Wu PC, Wong VCW, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am. J. Epidemiol. 1987; 126: 492-9.
3. Niederau C, Heintges T, Lange S et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N. Engl. J. Med. 1996; 334: 1422-7.
4. Lai CL, Ching CK, Tung AKM et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial. Hepatology 1997; 25: 241-4.
5. Lai CL, Chien RN, Leung NWY et al. A one year trial of lamivudine for chronic hepatitis B. N. Engl. J. Med. 1998; 339: 61-8.
6. Lai CL, Liaw YF, Leung NWY et al. Genotypic resistance to lamivudine in a prospective placebo-controlled multicentre study in Asia of lamivudine therapy for chronic hepatitis B infection: Incidence, kinetics of emergence and correlation with disease parameters. Hepatology 1997; 26: 259A.
7. Averett DR, Mason WS. Evaluation of drugs for antiviral activity against hepatitis B virus. Viral Hepatitis Review 1995; 1: 129-42.